Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFFO2 encodes a protein of the intermediate filament superfamily, essential for maintenance of cytoskeletal integrity and structural support within cells[7][1][3]. Its function appears to involve mechanical stability and regulation of cell morphology, consistent with other intermediate filaments[3][5]. A circular RNA derived from the IFFO2 locus (circ_IFFO2) is downregulated in cutaneous squamous cell carcinoma, implying possible roles in post-transcriptional regulation and cancer progression[1]. In livestock, genetic association studies suggest involvement in oxidative stress response and muscle control, potentially impacting feed efficiency[1]. No direct therapeutic, drug-targeting, or receptor-mediated roles are established for IFFO2 at present, and specific molecular functions remain under investigation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intermediate filament family orphan 2 (IFFO2).